Search

everythinglearnresearchcommunity

for

Search:↓

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Vertex pattern hair loss linked to higher prostate cancer risk.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

People undergoing chemotherapy need better support and information to cope with hair loss.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Chemical peels are effective and popular for treating men's skin issues, with some special considerations for their unique skin needs.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Some congenital hair disorders improve with age and can be managed with treatments like minoxidil, retinoids, supplements, and gentle hair care, but there's no cure.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Children with Epidermolysis Bullosa need better access to specialized dental care.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

More research is needed to improve telemedicine in primary care.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with rheumatoid arthritis have poorer sleep quality than healthy individuals.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

The risks of testosterone implants in women outweigh the benefits.

Finasteride increases risk of sleep apnea and insomnia.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.